Association of different fractionation schedules for prophylactic cranial irradiation with toxicity and brain metastases-free survival in stage III non-small cell lung cancer: A pooled analysis of individual patient data from three randomized trials.

Saved in:
Bibliographic Details
Title: Association of different fractionation schedules for prophylactic cranial irradiation with toxicity and brain metastases-free survival in stage III non-small cell lung cancer: A pooled analysis of individual patient data from three randomized trials.
Authors: Witlox WJA; Department of Clinical Epidemiology and Medical Technology Assessment, Maastricht University Medical Centre (MUMC), The Netherlands; Department of Radiation Oncology (Maastro Clinic), Maastricht University Medical Centre (MUMC), The Netherlands. Electronic address: willem.witlox@mumc.nl., Ramaekers BLT; Department of Clinical Epidemiology and Medical Technology Assessment, Maastricht University Medical Centre (MUMC), The Netherlands., Lacas B; Department of Biostatistics and Epidemiology, Gustave Roussy, University Paris-Saclay, Villejuif, France; Oncostat U1018, Inserm, University Paris-Saclay, labeled Ligue Contre le Cancer, Villejuif, France., Pechoux CL; Department of Radiation Oncology, Gustave Roussy, Paris-Saclay University, Villejuif, France., Sun A; Princess Margaret Cancer Centre, Department of Radiation Oncology, University of Toronto, Canada., Wang SY; Department of Thoracic Surgery, Sun Yat-sen University Cancer Center, Guangzhou, China., Hu C; NRG Oncology Statistics and Data Management Center, Philadelphia, United States; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, United States., Redman M; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, United States., van der Noort V; Department of Biometrics, Netherlands Cancer Institute (NKI), Amsterdam, The Netherlands., Li N; Department of Experimental Research, Sun Yat-sen University Cancer Center, Guangzhou, China., Guckenberger M; Department of Radiation Oncology, University Hospital Zurich, University of Zurich, Switzerland., van Tinteren H; Trial and Data Center, Princess Maxima Center for Pediatric Oncology, Utrecht, The Netherlands., Groen HJM; Department of Pulmonary Diseases, University of Groningen and University Medical Center Groningen, The Netherlands., Joore MA; Department of Clinical Epidemiology and Medical Technology Assessment, Maastricht University Medical Centre (MUMC), The Netherlands; Care and Public Health Research Institute (CAPHRI), Maastricht University, The Netherlands., De Ruysscher DKM; Department of Radiation Oncology (Maastro Clinic), Maastricht University Medical Centre (MUMC), The Netherlands.
Source: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology [Radiother Oncol] 2021 Nov; Vol. 164, pp. 163-166. Date of Electronic Publication: 2021 Oct 04.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Elsevier Scientific Publishers Country of Publication: Ireland NLM ID: 8407192 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0887 (Electronic) Linking ISSN: 01678140 NLM ISO Abbreviation: Radiother Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1879-0887
DOI:10.1016/j.radonc.2021.09.029